In this seminar, representatives from Linklaters will cover key enforcement trends in the past year, as well as provide you with insights into proceedings in the Competition Tribunal. We will also discuss how this is relevant to the pharmaceutical industry in Hong Kong and practical tips to ensure full compliance with competition law.
The "Symposium - How AI is Transforming Drug Discovery and Clinical Trial Design" was a huge success, with drug developers and investors in attendance to learn about the latest AI technologies in drug discovery and clinical development.
Topic: Introduction of the first Advanced Therapy Product GMP Facility in Hong Kong Speaker: Dr. Daniel Lee, Associate Vice-President (Innovation and Enterprise), The Chinese University of Hong Kong Language: English Target […]
[Speakers and Language updated] Webinar topics and speakers: The newly announced designated healthcare institution: preparation and expectation in importing HK-registered drugs and medical devices to the GBA – Dr. Michael […]
Digitalization impact every corner of society and every walk of life in particular under the Covid pandemic. Meanwhile, health literacy is another global issue. Adoption and adherence to treatment options […]